Tafenoquine
TQ-BA-2024-1
Phase 2 small_molecule active
Quick answer
Tafenoquine for Babesiosis is a Phase 2 program (small_molecule) at 60 DEGREES PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- 60 DEGREES PHARMACEUTICALS, INC.
- Indication
- Babesiosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active